BR9812974A - Anticorpos monoclonais antiidiotìpicos, seu uso na imunoterapia ativa de tumores malignos e composições contendo os mesmos - Google Patents

Anticorpos monoclonais antiidiotìpicos, seu uso na imunoterapia ativa de tumores malignos e composições contendo os mesmos

Info

Publication number
BR9812974A
BR9812974A BR9812974-0A BR9812974A BR9812974A BR 9812974 A BR9812974 A BR 9812974A BR 9812974 A BR9812974 A BR 9812974A BR 9812974 A BR9812974 A BR 9812974A
Authority
BR
Brazil
Prior art keywords
malignant tumors
monoclonal antibody
compositions containing
same
active immunotherapy
Prior art date
Application number
BR9812974-0A
Other languages
English (en)
Inventor
Ana Maria Vazquez Lopez
Rolando Perez Rodriguez
Eladio Iglesias Sierra
Alexis Perez Gonzalez
Gumersinda Bombino Lopez
Irene Beausoleil Delgado
Original Assignee
Centro Inmunologia Molecular
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro Inmunologia Molecular filed Critical Centro Inmunologia Molecular
Publication of BR9812974A publication Critical patent/BR9812974A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4266—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Patente de Invenção: <B>"ANTICORPOS MONOCLONAIS ANTIIDIOTìPICOS, SEU USO NA IMUNOTERAPIA ATIVA DE TUMORES MALIGNOS E COMPOSIçõES CONTENDO OS MESMOS". Anticorpo monoclonal antiidiotípico que é específico contra resíduos de N-glicolila de gangliosídeos, particularmente aqueles expressos por células cancerígenas. O anticorpo monoclonal é útil como um imunomodulador para o tratamento de câncer. Especificamente, o anticorpo monoclonal antild da presente invenção é capaz de induzir uma resposta predominantemente antiidiotípica em modelos xenogenéicos. O anticorpo monoclonal antiidiotípico também exerce um efeito protetor contra tumores malignos em animais.
BR9812974-0A 1997-10-21 1998-10-21 Anticorpos monoclonais antiidiotìpicos, seu uso na imunoterapia ativa de tumores malignos e composições contendo os mesmos BR9812974A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU1997119A CU22702A1 (es) 1997-10-21 1997-10-21 Anticuerpos monoclonales anti - idiotipo, su uso en la inmunoterapia activa de tumores malignos, hibridoma que los produce y composiciones que los contienen
PCT/CU1998/000007 WO1999020656A1 (es) 1997-10-21 1998-10-21 Anticuerpos monoclonales anti-idiotipos, su uso en la inmunoterapia activa de tumores malignos, y composiciones que los contienen

Publications (1)

Publication Number Publication Date
BR9812974A true BR9812974A (pt) 2000-08-08

Family

ID=5459399

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9812974-0A BR9812974A (pt) 1997-10-21 1998-10-21 Anticorpos monoclonais antiidiotìpicos, seu uso na imunoterapia ativa de tumores malignos e composições contendo os mesmos

Country Status (20)

Country Link
EP (1) EP1027375B1 (pt)
JP (1) JP4304287B2 (pt)
KR (1) KR100567209B1 (pt)
CN (1) CN1210309C (pt)
AR (1) AR017369A1 (pt)
AT (1) ATE341564T1 (pt)
AU (1) AU1019999A (pt)
BR (1) BR9812974A (pt)
CA (1) CA2308142C (pt)
CO (1) CO5060487A1 (pt)
CU (1) CU22702A1 (pt)
CY (1) CY1105844T1 (pt)
DE (1) DE69836096T2 (pt)
DK (1) DK1027375T3 (pt)
EA (1) EA003366B1 (pt)
ES (1) ES2274584T3 (pt)
HK (1) HK1034264A1 (pt)
PT (1) PT1027375E (pt)
SI (1) SI1027375T1 (pt)
WO (1) WO1999020656A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23007A1 (es) * 2001-04-06 2004-12-17 Ct De Inmunologia Molecular Ct De Inmunologia Mole Combinaciones inmunoterapéuticas para el tratamiencombinaciones inmunoterapéuticas para el tratamiento de tumores que sobre-expresan gangliósidos to de tumores que sobre-expresan gangliósidos
WO2011051466A1 (en) * 2009-11-02 2011-05-05 Novartis Ag Anti-idiotypic fibronectin-based binding molecules and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010221A1 (en) * 1991-11-13 1993-05-27 The Regents Of The University Of California Chimeric murine/human anti-idiotype monoclonal antibodies
US5653977A (en) * 1993-09-09 1997-08-05 Uab Research Foundation Anti-idiotypic antibody that mimics the GD2 antigen
ES2166770T3 (es) * 1993-12-09 2002-05-01 Centro Inmunologia Molecular Anticuerpos monoclonales contra gangliosidos y sus utilizaciones en la inmunoterapia activa especifica de tumores malignos.
CU22420A1 (es) * 1993-12-29 1996-01-31 Centro Inmunologia Molecular Composicion vacunal para el desarrollo de una respuesta contra gangliosidos n glicolilados y su uso para el tratamiento del cancer
CU22585A1 (es) * 1995-11-17 1999-11-03 Centro Inmunologia Molecular Anticuerpos monoclonales antiidiótipos (ab2) de tipo igg con alta conectividad idiotípica y composiciones farmacéuticas que los contienen. su uso como inmunoreguladores de la respuesta inmune.
US5792455A (en) * 1996-03-21 1998-08-11 Sloan-Kettering Institute For Cancer Research Anti-idiotypic antibody vaccines

Also Published As

Publication number Publication date
KR100567209B1 (ko) 2006-04-03
CO5060487A1 (es) 2001-07-30
HK1034264A1 (en) 2001-10-19
DE69836096D1 (de) 2006-11-16
SI1027375T1 (sl) 2007-02-28
DK1027375T3 (da) 2007-02-05
EA003366B1 (ru) 2003-04-24
CU22702A1 (es) 2001-07-31
JP4304287B2 (ja) 2009-07-29
AU1019999A (en) 1999-05-10
PT1027375E (pt) 2007-01-31
DE69836096T2 (de) 2007-05-16
WO1999020656A1 (es) 1999-04-29
EA200000442A1 (ru) 2000-10-30
JP2001520034A (ja) 2001-10-30
CY1105844T1 (el) 2011-02-02
ATE341564T1 (de) 2006-10-15
KR20010031283A (ko) 2001-04-16
CN1210309C (zh) 2005-07-13
CN1279692A (zh) 2001-01-10
CA2308142A1 (en) 1999-04-29
EP1027375A1 (en) 2000-08-16
AR017369A1 (es) 2001-09-05
ES2274584T3 (es) 2007-05-16
EP1027375B1 (en) 2006-10-04
CA2308142C (en) 2005-06-14

Similar Documents

Publication Publication Date Title
PT98710A (pt) Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem
NO20001104L (no) Humaniserte antistoff mot humant gp39, sammensetninger inneholdende slike samt terapeutiske anvendelser derav
BR0315157A (pt) Métodos de tratar doença de alzheimer empregando-se anticorpos direcionados contra peptìdeo beta amilóide e composições deste
ES2183186T3 (es) Composiciones cosmeticas en polvo que contienen elastomeros de silicona.
BR9907189A (pt) Produtos da fração lipìdica do carotenóide de pepino do mar e métodos de uso
RU95113862A (ru) Производные пирролопиримидинов, фармацевтическая композиция, промежуточные соединения
NO994983D0 (no) Fremgangsmåte for fremstilling av anti-humane antigenreseptorer, samt anvendelse av disse
DE59508864D1 (de) MONOKLONALER ANTIKÖRPER GEGEN CD44v6
NL300350I1 (nl) Geneesmiddelen met monoclonale antilichamen, die specifiek zijn voor de menselijk epidermale groeifactorreceptor
ES2185241T3 (es) Utilizacion de composiciones cosmeticas que contienen al menos una uxina.
PT873332E (pt) Compostos discodermolida e composicoes farmaceuticas que os contem para terapeutica do cancro
FI831230A0 (fi) N-glykosylerade karboxylsyraamidderivat, foerfarande foer deras framstaellning samt deras anvaendnifoer att paoverka kroppens eget foersvar
ES2038270T3 (es) Preparaciones topicas sebosupresoras.
TR200102034T2 (tr) Anti kanser aşılaması için antikorların kullanılması
ATE449847T1 (de) Hepatitis c rezeptorprotein cd81
BR0015597A (pt) Uso de anticorpos como vacinas
BR9812974A (pt) Anticorpos monoclonais antiidiotìpicos, seu uso na imunoterapia ativa de tumores malignos e composições contendo os mesmos
TR199801915T2 (xx) Benzotiofenler, bunlar� ihtiva eden form�lasyonlar ve y�ntemler.
BR9306663A (pt) Regiões antigênicas de complexos de partículas liberadas por tumores (TLP) e anticorpos contra os mesmos
FI900646A0 (fi) Foerfarande foer framstaellning av fenylhydrazoner och ur dessa erhaollna laekemedel och kosmetiska aemnen.
NO961423D0 (no) Oligopeptider avledet fra C-reaktive proteinfragmenter
SE8702734D0 (sv) Monoclonal antibodies to pseudomonas aeruginosa flagella
ES2090331T3 (es) Ctaa 28a32, antigeno reconocido por mca 28a32.
DK316188D0 (da) Sulfolipopolysaccharider som stimolatorer for den ikke specifikke forsvarsmekanisme
AU7079300A (en) Compositions and methods for the treatment of immune related diseases

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07F Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]